The Cigna Group (CI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,212,000 | 5,420,000 | 4,282,000 | 2,647,000 | 1,171,000 |
| Depreciation Amortization | 717,000 | 2,923,000 | 2,180,000 | 1,446,000 | 715,000 |
| Income taxes - deferred | -134,000 | -216,000 | -104,000 | -80,000 | -35,000 |
| Accounts payable and accrued liabilities | 11,000 | 2,038,000 | -54,000 | -520,000 | -222,000 |
| Other Working Capital | -87,000 | -879,000 | -3,455,000 | -3,297,000 | -888,000 |
| Other Operating Activity | 311,000 | -2,095,000 | 67,000 | 601,000 | 352,000 |
| Operating Cash Flow | $2,030,000 | $7,191,000 | $2,916,000 | $797,000 | $1,093,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -288,000 | -1,154,000 | -850,000 | -500,000 | -242,000 |
| Net Acquisitions | -57,000 | -1,894,000 | -1,897,000 | -1,836,000 | N/A |
| Purchase Of Investment | -1,730,000 | -6,434,000 | -4,743,000 | -3,264,000 | -1,617,000 |
| Sale Of Investment | 1,757,000 | 5,774,000 | 3,705,000 | 2,517,000 | 1,142,000 |
| Other Investing Activity | -6,000 | 97,000 | 51,000 | 59,000 | 0 |
| Investing Cash Flow | $-324,000 | $-3,611,000 | $-3,734,000 | $-3,024,000 | $-717,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -463,000 | 975,000 | 1,633,000 | 472,000 | -1,030,000 |
| Debt Issued | 0 | 4,260,000 | 4,260,000 | 4,260,000 | 4,262,000 |
| Debt Repayment | 0 | -4,714,000 | -4,714,000 | -4,714,000 | -4,325,000 |
| Common Stock Issued | 93,000 | 326,000 | 301,000 | 290,000 | 204,000 |
| Common Stock Repurchased | -1,368,000 | -7,742,000 | -6,321,000 | -3,710,000 | -2,794,000 |
| Dividend Paid | -357,000 | -1,341,000 | -1,017,000 | -687,000 | -345,000 |
| Other Financing Activity | -76,000 | 24,000 | 17,000 | -24,000 | -23,000 |
| Financing Cash Flow | $-2,171,000 | $-8,212,000 | $-5,841,000 | $-4,113,000 | $-4,051,000 |
| Exchange Rate Effect | -23,000 | -65,000 | -46,000 | -27,000 | -26,000 |
| Beginning Cash Position | 5,548,000 | 10,245,000 | 10,245,000 | 10,245,000 | 10,245,000 |
| End Cash Position | 5,060,000 | 5,548,000 | 3,540,000 | 3,878,000 | 6,544,000 |
| Net Cash Flow | $-488,000 | $-4,697,000 | $-6,705,000 | $-6,367,000 | $-3,701,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,030,000 | 7,191,000 | 2,916,000 | 797,000 | 1,093,000 |
| Capital Expenditure | -288,000 | -1,154,000 | -850,000 | -500,000 | -242,000 |
| Free Cash Flow | 1,742,000 | 6,037,000 | 2,066,000 | 297,000 | 851,000 |